Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
- Authors:
- USP affiliated authors: GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; WEGENER, SÂMIA REGIANE LOURENÇO JOCA - FCFRP ; SARTIM, ARIANDRA GUERINI - FCFRP ; SILVEIRA, KENNIA MOURA - FCFRP ; NUNES, PEDRO HENRIQUE GOBIRA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.neuropharm.2021.108679
- Subjects: ANTIDEPRESSIVOS; COMPORTAMENTO ANIMAL; CANABINOIDES; DEPRESSÃO; HIPOCAMPO; ATIVIDADE MOTORA
- Keywords: S-Ketamine; Cannabidiol; Depression; Forced swim test; Hyperlocomotion; AMPA receptors
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuropharmacology
- ISSN: 0028-3908
- Volume/Número/Paginação/Ano: v. 195, art. 108679, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 29 dez. 2025. -
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679 -
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679 -
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679 - CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects
- Orexin A injection into the ventral medial prefrontal cortex induces antidepressant-like effects: possible involvement of local Orexin-1 and Trk receptors
- Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- Effects of inhibition of neuronal nitric oxide synthase(nNOS) on FOS expression in the rat brain
- Impaired emotional response to stress in mice lacking galectin-1 or galectin-3
- Intra-hippocampal injection of cannabidiol induces antidepressant-like effect in the rat forced swimming test
- Inhibition of nNOS and sGC in the dorsal hippocampus induces antidepressant-like effects in rats
- Antidepressant-like effects of N-acetyl-L-cysteine in rats
- Purinergic receptor blockade induces antidepressant-and anticompulsive-like effects
Informações sobre o DOI: 10.1016/j.neuropharm.2021.108679 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
